Par Pharmaceutical, headquartered in Chestnut Ridge, NY, develops, manufactures and markets safe, innovative and cost-effective generic pharmaceutical products that help improve patient quality of life. Par offers differentiated, specialty dosage and sterile injectable drug products and is advancing a R&D pipeline of potential new products.

The recent combination of the Qualitest and Par businesses (known collectively as Par Pharmaceutical) expands Endo's generics business to a top five industry leader. Par Pharmaceutical is an operating company of Endo International plc (NASDAQ: ENDP) (TSX: ENL), a global specialty pharmaceutical company focused on improving patients' lives while creating shareholder value.

Parent Company
Endo International
Chestnut Ridge, US
Par Pharmaceutical was founded in 1978 and is headquartered in Chestnut Ridge, US
Report incorrect company information

Par Pharmaceutical Office Locations

Par Pharmaceutical has an office in Chestnut Ridge
Chestnut Ridge, US (HQ)
1 Ram Ridge Rd
Show all (1)
Report incorrect company information

Par Pharmaceutical Financials and Metrics

Summary Metrics

Founding Date



Par Pharmaceutical is a subsidiary of Endo International

Par Pharmaceutical Financials

Par Pharmaceutical's revenue was reported to be $246.14 m in FY, 2014
USDFY, 2013FY, 2014


246.1 m246.1 m

Revenue growth, %


(29.8 m)(29.8 m)

EBIT margin, %

USDFY, 2013FY, 2014


130.1 m244.4 m

Accounts Receivable

143.3 m158.7 m


117.3 m154.7 m

Current Assets

465.6 m653.1 m
USDFY, 2013FY, 2014

Net Income

(32.5 m)(32.5 m)

Depreciation and Amortization

50.3 m50.3 m
Show all financial metrics
Report incorrect company information